30.09.20: Bayer to accelerate transformation to address challenging market environment and enable additional growth investments

Bayer to accelerate transformation to address challenging market environment and enable additional growth investmentsAdjusted outlook for 2020 confirmed / 2021 sales expected at approximately 2020 levels despite significant headwinds from COVID-19 pandemic; 2021 core earnings per share expected to be slightly below 2020 levels at constant exchange rates / Lower than expected outlook in the agricultural market likely to lead to mid-to-high single-digit billion-euro non-cash impairment charges in the Crop Science business / Strengthening margin profile and funding of additional investments in innovation and growth through additional operational savings, targeted at more than 1.5 billion euros annually as of 2024 / Dividend policy to remain unchanged, payout ratio planned at lower end of 30-to-40 percent range of core earnings per share in the coming yearsmehr ...
Source: Bayer IR Newsfeed: Events - Category: Pharmaceuticals Source Type: news